Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The RIGHT Foundation (Research Investment for Global Health Technology Foundation) is a South Korean public-private partnership established to support the research and development of health technologies for global health equity. It is funded by the South Korean Ministry of Health and Welfare, the Bill & Melinda Gates Foundation, and several leading South Korean life science companies. The foundation provides grants for the development of vaccines, therapeutics, and diagnostics specifically targeting infectious diseases that disproportionately affect developing nations. By leveraging South Korea's R&D and manufacturing capabilities, the RIGHT Foundation aims to accelerate the availability of affordable and effective health interventions worldwide. Its portfolio includes significant projects in cholera, malaria, tuberculosis, and pandemic preparedness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RIGHT Fund.